3-D in the OR: a better view from many angles

Early adopters are finding advantages ergonomically, surgically and educationally.

By Karen Blum, Contributing

As I See It

‘X’ marks the eye and sometimes the lie

By Paul S. Koch, MD

Assessing the dry eye drug pipeline

Many new concepts show promise.

By Salim Butrus, MD, Rana

Bring the unhappy IOL patient back from the brink

How to get VA back on track despite unrealistic patient expectations.

By David A. Goldman, MD

Coding & Reimbursement

What to do with an overpayment

By Suzanne L. Corcoran, COE

Corneal Clarity

Is conjunctivochalasis on your dry eye radar?

By Thomas John, MD

Countdown to ICD-10

Follow these 10 steps to avoid the looming cash crunch.

By JOSEPH BURNS

Flatten the femto-phaco learning curve

This step-wise process can get you up to speed quickly with ReLACS.

By Kendall E. Donaldson, MD, MS

How systemic disease influences dry eye

Recognizing the signs and symptoms early is key to effective management.

How to be a dry eye 'center of excellence'

With effective and efficient testing and treatment in demand, a new revenue stream is before us.

By Marguerite McDonald, MD, FACS

IT Adviser

How to make your practice look good on all devices

By Joe Dysart

Management Essentials

Global periods: a benefit to patients, a drain on practices

By By Farrell

New Product Report

Quick Hits

Large blepharitis study has mixed results; Pain thresholds affect dry eye symptoms; New feature: Tip of the month; and more

Restasis: 10 years after launch

The drug has found a strong niche in dry eye therapy.

By Jerry Helzner, contributing editor

Spotlight on Technology & Technique

IOL injection device improved to combat damage, particulates

By Bill Kekevian, Senior

The ins and outs of outsourcing the optical shop

Doubling the profits and halving the stress — but with a cost.

By Brian P. Dunleavy

Viewpoint

Who really wins with ICD-10?